Galux
Dogokdong
About Galux
Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases using its AI-based drug design platform technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $36.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2026)
- Website: galux.co.kr
- Phone: +82 2 889 0908
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Medical, Product Research, Professional Services
Social Profiles
Canonical: https://fsome.com/organization/galux-5476 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.